A study by Hobbs and colleagues in a knock-in ET mouse model found that JAK2-V617F mutation initiates inherent changes in the formation of platelets from megakaryocytes and also alters their reactivity [109]. This evidence concerns the gene JAK2 and essential thrombocythemia.